These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15647289)

  • 1. Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1.
    Kobayashi Y; Mizoguchi T; Take I; Kurihara S; Udagawa N; Takahashi N
    J Biol Chem; 2005 Mar; 280(12):11395-403. PubMed ID: 15647289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells.
    Nukaga J; Kobayashi M; Shinki T; Song H; Takada T; Takiguchi T; Kamijo R; Hasegawa K
    J Periodontol; 2004 Feb; 75(2):249-59. PubMed ID: 15068113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice.
    Li X; Pilbeam CC; Pan L; Breyer RM; Raisz LG
    Bone; 2002 Apr; 30(4):567-73. PubMed ID: 11934647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles.
    Wei X; Zhang X; Zuscik MJ; Drissi MH; Schwarz EM; O'Keefe RJ
    J Bone Miner Res; 2005 Jul; 20(7):1136-48. PubMed ID: 15940366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidoglycan-induced IL-6 production in RAW 264.7 macrophages is mediated by cyclooxygenase-2, PGE2/PGE4 receptors, protein kinase A, I kappa B kinase, and NF-kappa B.
    Chen BC; Liao CC; Hsu MJ; Liao YT; Lin CC; Sheu JR; Lin CH
    J Immunol; 2006 Jul; 177(1):681-93. PubMed ID: 16785567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo.
    Li X; Tomita M; Pilbeam CC; Breyer RM; Raisz LG
    Prostaglandins Other Lipid Mediat; 2002 Apr; 67(3-4):173-80. PubMed ID: 12013525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL.
    Huang H; Ryu J; Ha J; Chang EJ; Kim HJ; Kim HM; Kitamura T; Lee ZH; Kim HH
    Cell Death Differ; 2006 Nov; 13(11):1879-91. PubMed ID: 16498455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor.
    Ono K; Kaneko H; Choudhary S; Pilbeam CC; Lorenzo JA; Akatsu T; Kugai N; Raisz LG
    J Bone Miner Res; 2005 Jan; 20(1):23-9. PubMed ID: 15619666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL.
    Tsujisawa T; Inoue H; Nishihara T
    J Bone Miner Res; 2005 Jan; 20(1):15-22. PubMed ID: 15619665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C.
    Fiebich BL; Schleicher S; Spleiss O; Czygan M; Hüll M
    J Neurochem; 2001 Dec; 79(5):950-8. PubMed ID: 11739606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
    Zhang Z; Jimi E; Bothwell AL
    J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro.
    Li X; Okada Y; Pilbeam CC; Lorenzo JA; Kennedy CR; Breyer RM; Raisz LG
    Endocrinology; 2000 Jun; 141(6):2054-61. PubMed ID: 10830290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors.
    Kobayashi Y; Take I; Yamashita T; Mizoguchi T; Ninomiya T; Hattori T; Kurihara S; Ozawa H; Udagawa N; Takahashi N
    J Biol Chem; 2005 Jun; 280(25):24035-42. PubMed ID: 15834134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor.
    Huber DM; Bendixen AC; Pathrose P; Srivastava S; Dienger KM; Shevde NK; Pike JW
    Endocrinology; 2001 Sep; 142(9):3800-8. PubMed ID: 11517156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway.
    Tintut Y; Parhami F; Tsingotjidou A; Tetradis S; Territo M; Demer LL
    J Biol Chem; 2002 Apr; 277(16):14221-6. PubMed ID: 11827970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation.
    Mendez M; LaPointe MC
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2111-7. PubMed ID: 15626689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function.
    Li X; Udagawa N; Itoh K; Suda K; Murase Y; Nishihara T; Suda T; Takahashi N
    Endocrinology; 2002 Aug; 143(8):3105-13. PubMed ID: 12130576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.
    Zhang YH; Heulsmann A; Tondravi MM; Mukherjee A; Abu-Amer Y
    J Biol Chem; 2001 Jan; 276(1):563-8. PubMed ID: 11032840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.
    Zeng L; An S; Goetzl EJ
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.